Fenbufen and biphenylacetic acid inhibit platelet function and the arachidonate prostaglandin system.
D000818:Animals; D001095:Arachidonic Acids / Q000378:metabolism*; D001713:Biphenyl Compounds / Q000494:pharmacology; D001777:Blood Coagulation; D001792:Blood Platelets / Q000503:physiopathology*; D006801:Humans; D008297:Male; D051379:Mice; D010648:Phenylacetates / Q000494:pharmacology*; D010654:Phenylbutyrates; D010974:Platelet Aggregation; D011422:Propionates / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000096:biosynthesis; D011453:Prostaglandins / Q000378:metabolism*; D051381:Rats; D012131:Respiratory Insufficiency / Q000209:etiology / Q000473:pathology
D001095:Arachidonic Acids; D001713:Biphenyl Compounds; D010648:Phenylacetates; D010654:Phenylbutyrates; D011422:Propionates; D011453:Prostaglandins; C012776:biphenylylacetic acid; C010725:fenbufen; D011451:Prostaglandin-Endoperoxide Synthases